DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Shreeji Global FMCG Limited — Adoption of new line(s) of business

NSE 1 hr ago·22 Oct 2026, 10:49 am

Shreeji Global FMCG

Shreeji Global FMCG Limited has announced that it is expanding its operations by adopting new lines of business. This strategic move indicates the company's intent to diversify its revenue streams beyond its existing portfolio. The specific details of these new ventures have not been disclosed in the exchange filing.

For investors, this development is significant as it signals a shift in the company's growth strategy. It suggests the management is looking to tap into new market opportunities, which could potentially enhance the company's long-term profitability. However, the success of these new initiatives will depend on their execution and market reception.

Investors should monitor the company's future disclosures to understand the nature of these new business lines. Keeping an eye on the company's quarterly results will be crucial to gauge whether this diversification is yielding the expected benefits or if it requires further strategic adjustments.